{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=MultiHance&page=2", "query": { "intervention": "MultiHance", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=MultiHance&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-11T19:58:54.638Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00019604", "title": "Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Liver Cancer", "Metastatic Cancer", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "computed tomography", "type": "PROCEDURE" }, { "name": "magnetic resonance imaging", "type": "PROCEDURE" }, { "name": "positron emission tomography", "type": "PROCEDURE" }, { "name": "radiofrequency ablation", "type": "PROCEDURE" }, { "name": "radionuclide imaging", "type": "PROCEDURE" }, { "name": "ultrasound imaging", "type": "PROCEDURE" }, { "name": "fludeoxyglucose F 18 (FDG-PET)", "type": "RADIATION" }, { "name": "gadopentetate dimeglumine", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "RADIATION" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "1998-08", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2017-02-03", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00019604" }, { "nct_id": "NCT01988675", "title": "MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Brain Neoplasms" ], "interventions": [ { "name": "Whole Brain Irradiation", "type": "RADIATION" }, { "name": "Partial Brain Irradiation", "type": "RADIATION" }, { "name": "Neuropsychological Testing", "type": "BEHAVIORAL" }, { "name": "Quality of Life Questionnaire", "type": "BEHAVIORAL" }, { "name": "Magnetic Resonance Imaging (MRI) Assessments", "type": "DEVICE" } ], "intervention_types": [ "RADIATION", "BEHAVIORAL", "DEVICE" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 91, "start_date": "2004-08-26", "completion_date": "2014-06-03", "has_results": false, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01988675" }, { "nct_id": "NCT01836055", "title": "Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Sclerosis" ], "interventions": [], "intervention_types": [], "sponsor": "Wayne State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "20 Years to 59 Years" }, "enrollment_count": 19, "start_date": "2012-01", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2014-12-09", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01836055" }, { "nct_id": "NCT01416740", "title": "A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Shoulder Pain" ], "interventions": [ { "name": "Indirect MRA of shoulder", "type": "PROCEDURE" }, { "name": "Gadopentetate Dimeglumine", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2009-12", "completion_date": "2012-09", "has_results": false, "last_update_posted_date": "2014-03-26", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01416740" }, { "nct_id": "NCT03091803", "title": "QSM and Regional DCE MRI Permeability Using GOCART Technique", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Intracranial Neoplasm" ], "interventions": [ { "name": "Dynamic Contrast-Enhanced Magnetic Resonance Imaging", "type": "DEVICE" }, { "name": "Gadobenate Dimeglumine", "type": "DRUG" }, { "name": "Gadoterate Meglumine", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2017-04-04", "completion_date": "2021-04-04", "has_results": false, "last_update_posted_date": "2021-04-05", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03091803" }, { "nct_id": "NCT02123615", "title": "ASIS for GAMMAGARD in Primary Immunodeficiency", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Primary Immunodeficiency" ], "interventions": [ { "name": "Gadolinium For abdomen", "type": "DRUG" }, { "name": "Gadolinium For lower back", "type": "DRUG" }, { "name": "Efficacy of Gammagard subcutaneously at Week 12", "type": "DRUG" }, { "name": "Efficacy of Gammagard subcutaneously at Week 24", "type": "DRUG" }, { "name": "Efficacy of Gammagard subcutaneously at Week 36", "type": "DRUG" }, { "name": "Efficacy of Gammagard subdermally at Week 36", "type": "DRUG" }, { "name": "Efficacy of Gammagard subdermally at Week 12", "type": "DRUG" }, { "name": "Efficacy of Gammagard subdermally at Week 24", "type": "DRUG" }, { "name": "Adverse Reactions of Gammagard subcutaneously at Week 12", "type": "DRUG" }, { "name": "Adverse Reactions of Gammagard subcutaneously at Week 24", "type": "DRUG" }, { "name": "Adverse Reactions of Gammagard subcutaneously at Week 36", "type": "DRUG" }, { "name": "Adverse Reactions of Gammagard subdermally at Week 12", "type": "DRUG" }, { "name": "Adverse Reactions of Gammagard subdermally at Week 24", "type": "DRUG" }, { "name": "Adverse Reactions of Gammagard subdermally at Week 36", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ASIS Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2016-01", "completion_date": "2016-06", "has_results": false, "last_update_posted_date": "2015-06-24", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Westminster, California", "locations": [ { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02123615" }, { "nct_id": "NCT00600951", "title": "Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Renal Insufficiency" ], "interventions": [], "intervention_types": [], "sponsor": "Bracco Diagnostics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 366, "start_date": "2008-01", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2014-11-04", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Princeton, New Jersey", "locations": [ { "city": "Princeton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00600951" }, { "nct_id": "NCT02074150", "title": "ASIS for Botox in Upper Limb Spasticity", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Upper Limb Spasticity Unilaterally in Adults With History of Stroke", "Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors." ], "interventions": [ { "name": "Gadolinium", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 12,", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 24", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 30", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 12", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 24", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 30", "type": "DRUG" }, { "name": "Adverse Reactions of Botox intramuscularly", "type": "DRUG" }, { "name": "Adverse Reactions of Botox subdermally", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "li nguyen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2016-01", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2015-06-24", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "Westminster, California", "locations": [ { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02074150" }, { "nct_id": "NCT02080312", "title": "Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meniere's Disease" ], "interventions": [ { "name": "Magnevist (gadopentetate dimeglumine)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2012-01", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2016-02-12", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02080312" }, { "nct_id": "NCT00310544", "title": "Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myocardial Infarction" ], "interventions": [ { "name": "Magnevist (Gadopentetate dimeglumine, BAY86-4882)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 73, "start_date": "2006-03", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2014-12-15", "last_synced_at": "2026-09-11T19:58:54.638Z", "location_count": 6, "location_summary": "San Diego, California • Winston-Salem, North Carolina • Tulsa, Oklahoma + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Tulsa", "state": "Oklahoma" }, { "city": "Portland", "state": "Oregon" }, { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00310544" } ] }